IgG-subclass-specific CMV reactivity in bone marrow transplant recipients.
IgG subclasses of cytomegalovirus (CMV) antiviral antibodies were determined in 37 donor-recipient pairs of bone marrow transplants (BMT). Bone marrow transplant recipients, like healthy persons, have a restricted immune reactivity, producing mainly two types of anti-CMV IgG: IgG1 and IgG3. Passively transfused specific antibody subclasses were readily measurable. Take of the transplant could be detected from the production of subclass IgG antiviral antibody 1-3 months after BMT of seronegative recipients with marrow from seropositive donors. Patients with protracted CMV infections or other severe diseases initially also produced CMV IgG1 and IgG3, but anti-CMV subclass titers then decreased. In severe disease, CMV was isolated from blood cells as well as from urine. In moderate infections, in which the patients recovered, CMV was isolated from urine but usually not from blood, and a strong and durable antiviral subclass response was measured.
D000741:Anemia, Aplastic / Q000382:microbiology* / Q000628:therapy; D016026:Bone Marrow Transplantation; D003587:Cytomegalovirus / Q000276:immunology* / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D007938:Leukemia / Q000382:microbiology* / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000382:microbiology; D007951:Leukemia, Myeloid / Q000382:microbiology; D055728:Primary Myelofibrosis / Q000382:microbiology / Q000628:therapy
D007074:Immunoglobulin G